Skip to main content
. 2022 Mar 16;22:100421. doi: 10.1016/j.lanwpc.2022.100421

Table 4.

Evaluation of the effect of each wave on death during hospitalization.

Risk ratio
95%CI
P value
Parameters Univariable Multivariable Univariable Multivariable Univariable Multivariable
Effect of each wave
Wave 1 Reference
Wave 2 0.363 0.398 [0.312-0.423] [0.40-0.561] < 0.001 < 0.001
Wave 3 0.783 0.473 [0.694-0.886] [0.325-0.487] < 0.001 < 0.001
Other risk factors
Transfer from other facilities 3.916 1.629 [3.479-4.401] [1.390-1.906] < 0.001 < 0.001
Age 1.092 1.103 [1.088-1.097] [1.096-1.110] < 0.001 < 0.001
Male sex 1.322 1.872 [1.195-1.464] [1.621-2.165] < 0.001 < 0.001
Obesity (BMI>=25) 0.678 1.098 [0.593-0.773] [0.940-1.281] < 0.001 0.236
Cardiovascular and peripheral vascular diseaseA 4.989 1.521 [4.394-5.654] [1.277-1.805] < 0.001 < 0.001
Chronic Respiratory DiseaseB 4.728 1.675 [4.055-5.492] [1.367-2.043] < 0.001 < 0.001
Liver disease 2.281 2.459 [1.793-2.865] [1.780-3.347] < 0.001 < 0.001
Diabetes mellitus 2.377 1.388 [2.132-2.647] [1.199-1.605] < 0.001 < 0.001
Cerebrovascular Disease 3.965 1.370 [3.482-4.504] [1.455-1.632] < 0.001 < 0.001
Hypertension 2.291 0.790 [2.075-2.530] [0.688-0.906] < 0.001 < 0.001
Severe condition at admission 6.766 3.026 [6.075-7.546] [2.624-3.493] < 0.001 < 0.001

Abbreviations. BMI, body mass index; CI, confidence interval. A Cardiovascular and peripheral vascular disease includes myocardial infarction, congestive heart failure, and peripheral vascular disease. B Chronic respiratory disease was defined as pulmonary disease in patients who were dyspneic with slight activity and included chronic obstructive pulmonary disease.